![]() |
Kekst CNC is handling the Chapter 11 filing of Buffalo-based Athenex Inc., a biopharmaceutical company focused on cancer treatments.
The bankruptcy move, which follows the completion of a strategic review, is designed to facilitate the sale of its primary businesses.
Athenex CEO Johnson Lau said the company sought to be a leader in bringing innovative cancer treatments to the market and improving patient health outcomes.
It succeeded in gaining regulatory approval for tirbanibulin ointment in the US, Taiwan and some EU countries but received a regulatory setback from the US Food and Drug Administration for its oral paclitaxel product.
“This significant regulatory setback coupled with challenging biotech markets and the difficult economic environment, put tremendous pressure on our ability to continue to fund our business,” said Lau.
The company’s manufacturing plant in Clarence, NY, will continue to operate for at least 90 days to provide a supply of tirbanibulin to its commercial customers.
Lau’s goal is to identify purchases who will continue to develop Athenex’s drug candidates.
Kekst CNC’s Daniel Yunger, Wendi Kopsick, Rich Goldman, and Mark Fallati are working the Chapter 11 filing.
Publicis Groupe owns Kekst CNC.


C Street Advisory Group handles The Children’s Place as one of the only pure-play children’s specialty retailers files for Chapter 11 and plans to sell its more than 500 outlets.
Joele Frank handles HealthSpan Partners as it ups its $25 per share offer for Surgery Partners, which uses FTI Consulting for strategic communications counsel.
Wendy’s has turned to Collected Strategies as it rejects what it calls an inadequate, unsolicited and non-binding takeover bid from a group led by Nelson Peltz’s Trian Partners.
Collected Strategies and AdvisRy Partners will handle Kaz Resources when it goes public in a $2B deal during the first half of next year.
FGS Global handles Marvell Technology as the semiconductor giant agrees to acquire Lumentum, a Joele Frank client, in all all-stock transaction worth $115B.



